Date: 2025-12-29

Type: Progress Notes

Source: epic_ihe_xdm

Sarah Matson, PA - 12/29/2025 9:30 AM CSTFormatting of this note is different from the original.PATIENT NAME: Alexander R TowellDOB: 8/4/197512/29/25CHIEF COMPLAINT: Postoperative evaluation after robotic resection of 2 metastatic colorectal cancer sites to the liverHISTORY OF PRESENT ILLNESS: Mr. Towell is a 50 y.o. male s/p robotic resection of 2 metastatic colorectal cancer sites to the liver approximately 11 days ago, who presents for postoperative visit today. He denies complaintsCURRENT MEDICATIONS: Current Outpatient Medications: acetaminophen 500 mg capsule, Take 2 capsules (1,000 mg total) by mouth every 6 (six) hours, Disp: , Rfl: cetirizine (ZyrTEC) 10 mg tablet, Take 1 tablet (10 mg total) by mouth daily as needed for allergies or rhinitis, Disp: , Rfl: docusate sodium (COLACE) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipation, Disp: , Rfl: gabapentin (NEURONTIN) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day, Disp: 60 capsule, Rfl: 11 levothyroxine (SYNTHROID) 125 mcg tablet, Take 1 tablet (125 mcg total) by mouth early morning before breakfast, Disp: , Rfl: lidocaine (LIDODERM) 5 %, Place 1 patch on the skin daily for 12 hours Remove & discard patch(es) within 12 hours or as directed by MD, Disp: , Rfl: [Paused] loperamide (IMODIUM A-D) 2 mg tablet, Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrhea, Disp: , Rfl: LORazepam (ATIVAN) 0.5 mg tablet, Take 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxiety, Disp: 30 tablet, Rfl: 0 multivitamin with minerals tablet, Take 1 tablet by mouth early morning before breakfast, Disp: , Rfl: oxyCODONE (ROXICODONE) 5 mg immediate release tablet, Take 1 tablet (5 mg total) by mouth every 6 (six) hours as needed for pain, Disp: 10 tablet, Rfl: 0 [Paused] prochlorperazine (COMPAZINE) 10 mg tablet, Take 1 tablet (10 mg total) by mouth 3 (three) times a day as needed for nausea, Disp: 60 tablet, Rfl: 3 propranoloL (INDERAL) 20 mg tablet, Take 1 tablet (20 mg total) by mouth early morning before breakfast, Disp: , Rfl: senna-docusate (PERICOLACE) 8.6-50 mg, Take 1 tablet by mouth daily as needed for constipation, Disp: , Rfl: [Paused] zolpidem (AMBIEN) 5 mg tablet, Take 1 tablet (5 mg total) by mouth nightly as needed for sleep, Disp: 30 tablet, Rfl: 0ALLERGIES: No Known AllergiesREVIEW OF SYSTEMS: Denies fever/chills, weight loss, abdominal pain. PHYSICAL EXAM: VitalsBP 133/77 Pulse 51 Temp 36.4 °C (97.5 °F) Ht 185.4 cm (6’ 1") Wt 107.7 kg (237 lb 6.4 oz) BMI 31.32 kg/m² General Appearance: awake, alert, oriented x3, in no acute distress Skin: there are no suspicious lesions or rashes or jaundiceHead: NCAT, Eyes: EOMI and Sclera nonictericNeck: neck- suppleLungs: Chest wall: symmetricAbdomen: Soft, non-tender, no hernia, mass, or fluid collection appreciated. Incisions healing wellExtremities: no lower extremity edema bilaterallyASSESSMENT:50 y.o. male s/p robotic resection of 2 metastatic colorectal cancer sites to the liver LABS: Lab Results Component Value Date WBC 9.25 12/19/2025 HGB 14.3 12/19/2025 HCT 41.4 12/19/2025 Lab Results Component Value Date SODIUM 137 12/19/2025 POTASSIUM 4.2 12/19/2025 GLUCOSE 110 12/19/2025 BUNSER 13 12/19/2025 CREATININE 1.12 12/19/2025 SURGICAL PATHOLOGY:

Diagnosis: A. Liver, segment 5/8, resection: - Metastatic moderately-differentiated adenocarcinoma with necrosis, morphologically compatible with colorectal primary, in hepatic parenchyma. - Margin of resection, negative for carcinoma. B. Liver, segment 4B, resection: - Metastatic moderately-differentiated adenocarcinoma with necrosis, morphologically compatible with colorectal primary, in hepatic parenchyma. - Margin of resection, negative for carcinoma. PLAN: His surgical pathology was reviewed todayHe is scheduled for follow up with Dr. Tan in 2 weeksHe will call with questions or concerns. I, Sarah Matson, PA-C, MMS, have personally taken a history, examined the patient, and documented the assessment and plan as noted. The patient was seen in the Center for Advanced Medicine. Sarah Christine Matson, PA-C, MMSElectronically signed by Sarah Matson, PA at 01/09/2026 3:04 PM CSTdocumented in this encounter